Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions
B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations
  • Stanford University Stanford, California, United States
  • Stanford, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

eHealth for the Elderly

NCT04393090

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hämato-Onkologische Schwerpunktpraxis Aschaffenburg, Germany
  • Onkologie-Köln, Cologne, Germany
  • St.-Antonius-Hospital Eschweiler, Germany
  • Praxis am Albertinen- Krankenhaus Hamburg, Germany
View Trial Details
Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

NCT02322320

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 42 locations
View Trial Details
Completed

Pembrolizumab (MK-3475) in MM Patients With Residual Disease

NCT02636010

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clinic Barcelona, Spain
  • Hospital 12 de octubre Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
View Trial Details
Completed

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

NCT01660633

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
  • University of Massachusetts Worcester, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

NCT01383759

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions